A pill to treat COVID-19 from Pfizer significantly cut the risk of hospitalization and death in a clinical trial, the company has announced.
Pfizer said Friday its pill to treat COVID-19, Paxlovid, in a clinical trial was shown to reduce the risk of hospitalization or death by 89 percent when it was given within three days of the onset of symptoms, The New York Times reports. The trial consisted of participants "who are at high risk of progressing to severe illness," Pfizer said, and there were no deaths among the group treated with Paxlovid compared to 10 deaths in the placebo group, per ABC News.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Create an account with the same email registered to your subscription to unlock access.
-
Baffin Island: looking for narwhal in Arctic CanadaThe Week Recommends An exploration of this island between mainland Canada and Greenland is ideal for the adventurous at heart
-
Sudan's year of civil war: 'the world has turned its back'Talking Point
-
Crossword: April 28, 2024The Week's daily crossword
-
Blind people will listen to next week's total eclipseSpeed Read While they can't see the event, they can hear it with a device that translates the sky's brightness into music
-
Melting polar ice is messing with global timekeepingSpeed Read Ice loss caused by climate change is slowing the Earth's rotation
-
An amphibian that produces milk?speed read Caecilians, worm-like amphibians that live underground, produce a milk-like substance for their hatchlings
-
Jupiter's Europa has less oxygen than hopedspeed read Scientists say this makes it less likely that Jupiter's moon harbors life
-
Why February 29 is a leap daySpeed Read It all started with Julius Caesar
-
US spacecraft nearing first private lunar landingSpeed Read If touchdown is successful, it will be the first U.S. mission to the moon since 1972
-
Scientists create 'meaty' rice for eco-friendly proteinSpeed Read Korean scientists have invented a new hybrid food, consisting of beef muscle and fat cells grown inside grains of rice
-
New images reveal Neptune and Uranus in different colours than originally thoughtSpeed Read Voyager 2 images from the 1980s led to 'modern misconception'
